Literature DB >> 33566141

Olfactory bulb enlargement in neurofibromatosis type 1: report of a novel finding.

Alessandra D'Amico1,2, Martina Di Stasi2, Lorenzo Ugga2, Teresa Perillo3, Claudia Santoro4,5, Daniela Melis6.   

Abstract

Neurofibromatosis type 1 (NF1) is a genetic autosomal dominant disease caused by mutation of the protein neurofibromin, a regulator of cell growth. The most frequent intracranial findings are unidentified bright objects (UBOs), thickening of the corpus callosum, sphenoid wing dysplasia, cerebral vasculopathy, optic and non-optic pilocytic astrocytomas, and plexiform neurofibromas. We report two cases of NF1 patients with asymptomatic olfactory bulbs (OBs) enlargement depicted with Magnetic Resonance Imaging (MRI). To the best of our knowledge, this finding has not been reported in the scientific literature so far. We hypothesize that olfactory bulbs enlargement may have a pathogenetic nature like that of the UBOs as in one of our patients there was spontaneous regression during follow-up. The olfactory bulbs enlargement expands the broad neuroradiological spectrum of finding of NF1. More reports are required to better understand incidence, pathogenesis, and clinical behavior of olfactory bulbs enlargement in NF1 patients.

Entities:  

Keywords:  Magnetic Resonance Imaging; Neurofibromatosis type 1; Olfactory bulbs; Pediatrics

Year:  2021        PMID: 33566141     DOI: 10.1007/s00381-021-05077-z

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  11 in total

Review 1.  The olfactory system.

Authors:  N Leboucq; N Menjot de Champfleur; S Menjot de Champfleur; A Bonafé
Journal:  Diagn Interv Imaging       Date:  2013-08-07       Impact factor: 4.026

Review 2.  Neuroimaging of neurocutaneous diseases.

Authors:  Kaveer Nandigam; Laszlo L Mechtler; James G Smirniotopoulos
Journal:  Neurol Clin       Date:  2014-02       Impact factor: 3.806

3.  Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees.

Authors:  Gianni Bisogno; Pietro Soloni; Massimo Conte; Marta Podda; Andrea Ferrari; Alberto Garaventa; Roberto Luksch; Giovanni Cecchetto
Journal:  BMC Cancer       Date:  2012-03-25       Impact factor: 4.430

Review 4.  Neurofibromatosis.

Authors:  Bruce R Korf
Journal:  Handb Clin Neurol       Date:  2013

5.  Rhinencephalon changes in tuberous sclerosis complex.

Authors:  Renzo Manara; Davide Brotto; Samuela Bugin; Maria Federica Pelizza; Stefano Sartori; Margherita Nosadini; Sara Azzolini; Giorgio Iaconetta; Cecilia Parazzini; Alessandra Murgia; Angela Peron; Paola Canevini; Francesca Labriola; Aglaia Vignoli; Irene Toldo
Journal:  Neuroradiology       Date:  2018-06-17       Impact factor: 2.804

Review 6.  Cerebrovascular stenosis in neurofibromatosis type 1 and utility of magnetic resonance angiography: our experience and literature review.

Authors:  Felice D'Arco; Alessandra D'Amico; Ferdinando Caranci; Nilde Di Paolo; Daniela Melis; Arturo Brunetti
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

7.  Longitudinal evolution of unidentified bright objects in children with neurofibromatosis-1.

Authors:  Michael A Kraut; Joan P Gerring; Karen L Cooper; Richard E Thompson; Martha B Denckla; Walter E Kaufmann
Journal:  Am J Med Genet A       Date:  2004-08-30       Impact factor: 2.802

8.  Intractable epilepsy and olfactory bulb hamartoma. A case report.

Authors:  Andrew W McEvoy; Marcello Bartolucci; Thomas Revesz; William Harkness
Journal:  Stereotact Funct Neurosurg       Date:  2002       Impact factor: 1.875

9.  Olfactory hamartomas in tuberous sclerosis.

Authors:  G A de León; N Zaeri; C M Foley
Journal:  J Neurol Sci       Date:  1988-11       Impact factor: 3.181

Review 10.  Masses of the Nose, Nasal Cavity, and Nasopharynx in Children.

Authors:  Diana P Rodriguez; Emily S Orscheln; Bernadette L Koch
Journal:  Radiographics       Date:  2017-10       Impact factor: 5.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.